5.07.14 Two startups based on Berkeley Lab technologies made key personnel announcements this week. TeselaGen Biotechnology named veteran investor Tom Baruch as a board member. (For more information, go here.) The startup offers a synthetic biology platform to enable efficient, rapid prototyping of recombinant molecules. ProGDerm, an Allied Minds business venture, named J. Michael Delmage, Ph.D., as its CEO. (For the complete story, go here.) ProGDerm is developing a natural skin rejuvenation approach for anti-aging as well as medical treatment of wounds and degenerative skin conditions.